EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients. - Wikidata - wikimedia - TriplyDB

EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.

EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.

http://www.wikidata.org/entity/Q54417851

about

EZH2 methyltransferase and H3K27 methylation in breast cancer An overview of long non-coding RNAs in ovarian cancers Structural Context of Disease-Associated Mutations and Putative Mechanism of Autoinhibition Revealed by X-Ray Crystallographic Analysis of the EZH2-SET Domain Prognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysis Diverse involvement of EZH2 in cancer epigenetics Mining TCGA data using Boolean implications Polycomb group expression signatures in the malignant progression of gliomas.MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma EZH2: not EZHY (easy) to deal.Histones and their modifications in ovarian cancer - drivers of disease and therapeutic targets.EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion.Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer EZH2 depletion blocks the proliferation of colon cancer cells.TGF-β mediated DNA methylation in prostate cancer.Regulation and Role of EZH2 in Cancer The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells.MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2.EZH2, a unique marker of malignancy in effusion cytology.EZH2 regulates cofilin activity and colon cancer cell migration by targeting ITGA2 gene Enhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysis Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma.Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer.Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma.The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression.TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression Role of EZH2 in Epithelial Ovarian Cancer: From Biological Insights to Therapeutic Target EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer.Inhibition of EZH2 expression is associated with the proliferation, apoptosis, and migration of SW620 colorectal cancer cells in vitro.RanBP9/TSSC3 complex cooperates to suppress anoikis resistance and metastasis via inhibiting Src-mediated Akt signaling in osteosarcoma DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.Histone onco-modifications.Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma.Update of research on the role of EZH2 in cancer progression.Epigenetic modification in gliomas: role of the histone methyltransferase EZH2.Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis.Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer.Properties of Native High-Density Lipoproteins Inspire Synthesis of Actively Targeted In Vivo siRNA Delivery Vehicles.Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGFβ1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p.

P2860

Q24633788-CEC0AE7D-2166-4344-840A-F08F2C341BA0 Q26753467-DC6C5748-765B-439A-8914-C09629AEC91D Q27681087-B2333B2C-FB87-4ACC-B76C-4BD9CB3AA416 Q27853296-5D959AC5-CE54-4002-99FA-7E4881A6DF12 Q28084911-CF310A00-412A-4E03-9126-5CF1C44678B3 Q30838107-969231F6-87CE-4A93-8AAD-6241BF98E387 Q33599449-E67346CF-AE89-4F9D-BCA4-1854ADD809C0 Q33609359-4BB97D65-7C1A-46BB-8B83-E8871A311B91 Q33610902-02192CCD-8CFF-43F8-BFB4-BA317D21151F Q33741828-148A5861-81FB-48CF-A717-8191811D1E66 Q33804215-34D5B326-D62D-4427-A613-EE39C409269C Q33875597-9A7D5796-2BA3-49B2-903F-F92CBD96A8D7 Q33963796-47798DA7-0045-4E0B-9E11-5834186686F9 Q34039935-9F37F1A3-6593-4FC5-AE67-648811A45097 Q34043370-0F957583-B0FE-4BB2-ACD5-E8587F98C4FA Q34137728-A44996EF-CCD9-4BE4-B0A3-3542EEC7F5B2 Q34201826-3CBEF390-8E4C-4ACA-B2CE-36D0F3BE17D5 Q34569371-F8D018F2-D2A1-4EDB-8A31-3AEAD45C41F4 Q34699488-FE7D4BF6-E149-490B-B3CA-72EBF5E7CEBD Q34789991-6FB187F0-9E86-4AB2-B5AE-6E4607EB38E9 Q35606640-F3DEC229-6BB0-4444-822D-E9137174DCD8 Q35942323-35E9444A-3145-4847-8213-19814AB0C98D Q35955196-BC51F56A-3132-4C46-8894-9539A84D6F5D Q36105152-3CAE7085-ED13-48AB-A132-C8CE2092AD2C Q36338683-EC0C797E-348B-4E88-A49B-A1709A3C188A Q36439839-1CD12DAF-91F4-42BB-BC44-8D0D93CB2052 Q36679745-BFDA5667-BCE9-4B88-A089-C583061935B5 Q36998193-9F110639-0798-46FD-8F70-B136CD5E13D4 Q37071469-A6440AAB-4BA7-45C7-A2A9-A081A6303D8A Q37603522-24D09A34-9AA9-41FF-A3E2-C22EA8ECC921 Q37697488-C25E7CCC-CDF1-4F4F-ABA6-19DA57C5FC33 Q37708968-545F1409-BA81-46DA-95D2-66F8BCFBBC95 Q37868421-FBF9C3E1-E0F6-4B68-8F38-37731B6C344A Q38085112-5EBC5DE1-8B00-4770-9BFD-9F2BEAF38992 Q38099319-94CF0216-7AC3-460B-9478-8A456BA34F43 Q38232172-4E41A2F4-AAE3-48E0-AD59-3F6E43199037 Q38287628-A2E0B49F-06B0-47DE-A1FE-CA22D1BC33FE Q38326633-81443FBC-9D63-4A2D-85BD-0DF489205583 Q38674708-38909F8A-83B5-43B3-B42F-C5BD19BC7F6D Q38733932-55FC1E7B-8B13-4F29-9163-4448F2969486

P2860

EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.

http://www.wikidata.org/entity/Q54417851

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

EZH2 supports ovarian carcinom ...... in ovarian carcinoma patients.

@en

EZH2 supports ovarian carcinom ...... in ovarian carcinoma patients.

@nl

type

label

EZH2 supports ovarian carcinom ...... in ovarian carcinoma patients.

@en

EZH2 supports ovarian carcinom ...... in ovarian carcinoma patients.

@nl

prefLabel

EZH2 supports ovarian carcinom ...... in ovarian carcinoma patients.

@en

EZH2 supports ovarian carcinom ...... in ovarian carcinoma patients.

@nl

P1433

Q54417851-A8005B39-9862-4580-B34D-9E60F09B4D9F

P1476

Q54417851-23ECCA7B-807E-49CA-BB87-C32F6A645A13

P2093

Q54417851-00B1F26C-6127-488F-99AD-E73D599E7FD9

Q54417851-3388A25D-AD16-4248-A38C-BB123DC8F417

Q54417851-45411F95-47CE-4019-A870-191C50F8D04F

Q54417851-7BBDA63B-1E82-4FFF-B346-38214422DC4B

Q54417851-82240D38-5B5F-432E-B5E4-69DDEBF6F66F

Q54417851-89718DC9-7439-45CC-A592-E14C132E1FFD

Q54417851-A963086F-440F-424F-A4F2-28CBE639D587

Q54417851-AFA4A853-13AC-47C8-BE08-72C6A0D7A7AE

Q54417851-C23AD5DA-DD44-4FB7-99C2-118A44180AEC

Q54417851-FB54FA82-9CA8-4830-A7B0-BDE3AAB25BB6

P2860

Q54417851-013C136E-A018-4C06-B2A6-11062B527D83

Q54417851-086D64EC-3212-4232-8082-60298DDD1026

Q54417851-0910F068-60BF-455C-92D2-5CA318C5A5C5

Q54417851-1BA39E11-AA55-4C24-AFC5-5CC94BAFAD8F

Q54417851-20290BA7-FC29-4DEF-9C4A-57EE630637E1

Q54417851-28079942-F0C9-4A07-A1A8-3F4E848B3A77

Q54417851-38F256AA-9D97-4807-9F07-2256849FE59A

Q54417851-3C9ABE42-3F6A-4F34-A1F5-E40D0DE328B0

Q54417851-4813E9B7-DD0D-4B83-AEA4-35DA65066617

Q54417851-4F539D08-08F8-4493-BB61-A09BF9E15D08

P304

Q54417851-98B7DD56-171B-4818-8DD4-6216417305C2

P31

Q54417851-8F91336A-240E-44C3-9028-23E89B4E2DDA

P356

Q54417851-A569BFB4-8D34-41B8-8EC7-5375FD6E6043

P407

Q54417851-517B1E9E-00FA-44ED-A873-EB5965E0B776

P433

Q54417851-816C7896-74D2-470A-8A14-FEB37558A885

P478

Q54417851-261A27B9-08D3-428F-8491-150D9E5139D1

P50

Q54417851-16996781-DEEE-463E-83DB-16AD579857BB

Q54417851-8ED4568D-D8AA-448C-8B37-6FD28B88C987

P577

Q54417851-BF7A77F1-B033-4D7B-9BE0-600FDDE09933

P5875

Q54417851-F37FC538-DC31-44F9-831B-1C97F4D55856

P698

Q54417851-E49217E2-63C9-436E-B969-CE9282BBD773

P921

Q54417851-20092A09-2AE7-44F3-85F0-6214E028AB56

P356

P1433

P1476

EZH2 supports ovarian carcinom ...... in ovarian carcinoma patients

@en

P2093

Dan Xie

http://www.w3.org/2001/XMLSchema#string

Guo-Fen Yang

http://www.w3.org/2001/XMLSchema#string

Hai-Xia Deng

http://www.w3.org/2001/XMLSchema#string

Hsiang-Fu Kung

http://www.w3.org/2001/XMLSchema#string

Li-Ru He

http://www.w3.org/2001/XMLSchema#string

Mu-Yan Cai

http://www.w3.org/2001/XMLSchema#string

Shi-Juan Mai

http://www.w3.org/2001/XMLSchema#string

Wen-Feng Hua

http://www.w3.org/2001/XMLSchema#string

Yang-Chao Chen

http://www.w3.org/2001/XMLSchema#string

Yi-Ji Liao

http://www.w3.org/2001/XMLSchema#string

P2860

Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Cancer statistics, 2007

The polycomb group protein EZH2 is involved in progression of prostate cancer

Epidemiological and molecular aspects of ovarian cancer risk.

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder.

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells

The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3.

Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma.

P304

1576-1583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGQ150

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45406387

http://www.w3.org/2001/XMLSchema#string

P698

20668008

http://www.w3.org/2001/XMLSchema#string

P921